Stay updated with breaking news from Patrickd Yeramian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.03, Yahoo Finance reports. Amylyx Pharmaceuticals had a return on equity of 0.49% and a net margin of 0.62%. The firm had revenue […]
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) released its earnings results on Thursday. The company reported $0.23 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.03, Yahoo Finance reports. Amylyx Pharmaceuticals had a return on equity of 0.49% and a net margin of 0.62%. During the same quarter in the previous year, […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) was the target of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 5,440,000 shares, a decrease of 5.1% from the January 15th total of 5,730,000 shares. Approximately 10.9% of the shares of the stock are […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) – Equities researchers at Leerink Partnrs upped their FY2024 EPS estimates for shares of Amylyx Pharmaceuticals in a note issued to investors on Monday, January 29th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings per share of $1.45 for the year, up from […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 5,730,000 shares, an increase of 5.3% from the December 31st total of 5,440,000 shares. Approximately 11.5% of the company’s shares are sold short. […]